SALE EXTENDED
MarketBeat All Access
Start your 30-day free trial,
then continue your subscription for 50% off.
TODAY ONLY!
Claim Your Discount
×
S&P 500   3,639.66 (-2.80%)
DOW   29,296.79 (-2.11%)
QQQ   269.10 (-3.81%)
AAPL   140.09 (-3.67%)
MSFT   234.24 (-5.09%)
META   133.45 (-4.04%)
GOOGL   98.68 (-2.70%)
AMZN   114.56 (-4.77%)
TSLA   223.07 (-6.32%)
NVDA   120.76 (-8.03%)
NIO   13.76 (-6.84%)
BABA   81.24 (-3.65%)
AMD   58.44 (-13.87%)
T   14.94 (-2.48%)
MU   52.91 (-3.13%)
CGC   2.79 (-25.60%)
F   12.20 (-1.29%)
GE   64.56 (-2.51%)
DIS   97.16 (-2.88%)
AMC   6.53 (-8.29%)
PYPL   90.17 (-4.50%)
PFE   42.32 (-1.79%)
NFLX   224.75 (-6.36%)
S&P 500   3,639.66 (-2.80%)
DOW   29,296.79 (-2.11%)
QQQ   269.10 (-3.81%)
AAPL   140.09 (-3.67%)
MSFT   234.24 (-5.09%)
META   133.45 (-4.04%)
GOOGL   98.68 (-2.70%)
AMZN   114.56 (-4.77%)
TSLA   223.07 (-6.32%)
NVDA   120.76 (-8.03%)
NIO   13.76 (-6.84%)
BABA   81.24 (-3.65%)
AMD   58.44 (-13.87%)
T   14.94 (-2.48%)
MU   52.91 (-3.13%)
CGC   2.79 (-25.60%)
F   12.20 (-1.29%)
GE   64.56 (-2.51%)
DIS   97.16 (-2.88%)
AMC   6.53 (-8.29%)
PYPL   90.17 (-4.50%)
PFE   42.32 (-1.79%)
NFLX   224.75 (-6.36%)
S&P 500   3,639.66 (-2.80%)
DOW   29,296.79 (-2.11%)
QQQ   269.10 (-3.81%)
AAPL   140.09 (-3.67%)
MSFT   234.24 (-5.09%)
META   133.45 (-4.04%)
GOOGL   98.68 (-2.70%)
AMZN   114.56 (-4.77%)
TSLA   223.07 (-6.32%)
NVDA   120.76 (-8.03%)
NIO   13.76 (-6.84%)
BABA   81.24 (-3.65%)
AMD   58.44 (-13.87%)
T   14.94 (-2.48%)
MU   52.91 (-3.13%)
CGC   2.79 (-25.60%)
F   12.20 (-1.29%)
GE   64.56 (-2.51%)
DIS   97.16 (-2.88%)
AMC   6.53 (-8.29%)
PYPL   90.17 (-4.50%)
PFE   42.32 (-1.79%)
NFLX   224.75 (-6.36%)
S&P 500   3,639.66 (-2.80%)
DOW   29,296.79 (-2.11%)
QQQ   269.10 (-3.81%)
AAPL   140.09 (-3.67%)
MSFT   234.24 (-5.09%)
META   133.45 (-4.04%)
GOOGL   98.68 (-2.70%)
AMZN   114.56 (-4.77%)
TSLA   223.07 (-6.32%)
NVDA   120.76 (-8.03%)
NIO   13.76 (-6.84%)
BABA   81.24 (-3.65%)
AMD   58.44 (-13.87%)
T   14.94 (-2.48%)
MU   52.91 (-3.13%)
CGC   2.79 (-25.60%)
F   12.20 (-1.29%)
GE   64.56 (-2.51%)
DIS   97.16 (-2.88%)
AMC   6.53 (-8.29%)
PYPL   90.17 (-4.50%)
PFE   42.32 (-1.79%)
NFLX   224.75 (-6.36%)
NASDAQ:LXRX

Lexicon Pharmaceuticals - LXRX Insider Trading & Ownership

$2.29
-0.17 (-6.91%)
(As of 10/7/2022 12:00 AM ET)
Add
Compare
Today's Range
$2.27
$2.49
50-Day Range
$2.33
$3.43
52-Week Range
$1.31
$6.33
Volume
676,943 shs
Average Volume
964,780 shs
Market Capitalization
$420.50 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.00

Lexicon Pharmaceuticals (NASDAQ:LXRX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
6.50%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$40.43 M
Number Of
Insiders Selling
(Last 12 Months)
0

LXRX Insider Buying and Selling by Quarter

Get LXRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Lexicon Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


Lexicon Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/1/2022International S.C.A. ArtalDirectorBuy16,173,800$2.50$40,434,500.0048,433,261  
3/15/2021James F TessmerVPSell22,912$6.92$158,551.0471,766  
9/18/2019Alexander A SantiniEVPBuy4,500$3.36$15,120.0016,661  
9/17/2019Lonnel CoatsCEOBuy50,000$3.13$156,500.00127,639  
9/16/2019Christopher J SobeckiDirectorBuy25,000$2.55$63,750.00112,493  
9/13/2019Christopher J SobeckiDirectorBuy99,249$2.41$239,190.0913,645  
8/19/2019Lonnel CoatsInsiderBuy40,000$1.35$54,000.0087,695  
8/16/2019Lonnel CoatsCEOBuy37,000$1.35$49,950.0087,695  
8/2/2019James F TessmerVPBuy10,000$1.14$11,400.0043,368  
8/2/2019Sam L BarkerDirectorBuy24,000$1.18$28,320.0040,187  
6/28/2018Public Equities L.P. InvusDirectorBuy182,838$12.51$2,287,303.38  
6/25/2018Public Equities L.P. InvusDirectorBuy253,725$12.99$3,295,887.75  
6/21/2018Public Equities L.P. InvusDirectorBuy72,973$13.29$969,811.17  
6/18/2018Public Equities L.P. InvusDirectorBuy45,784$12.98$594,276.32  
6/14/2018Public Equities L.P. InvusDirectorBuy9,200$12.66$116,472.00  
6/11/2018Public Equities L.P. InvusDirectorBuy98,626$12.75$1,257,481.50  
6/8/2018James F TessmerVPSell10,000$12.91$129,100.0035,643  
6/8/2018Public Equities L.P. InvusDirectorBuy29,747$12.89$383,438.83  
6/6/2018Public Equities L.P. InvusDirectorBuy95,079$12.58$1,196,093.82  
6/4/2018Public Equities L.P. InvusDirectorBuy416,481$12.01$5,001,936.81  
6/1/2018Public Equities L.P. InvusDirectorBuy147,339$12.22$1,800,482.58  
5/30/2018Public Equities L.P. InvusDirectorBuy433,378$9.94$4,307,777.32  
5/25/2018Public Equities L.P. InvusDirectorBuy138,700$9.62$1,334,294.00  
5/23/2018Alexander A SantiniEVPBuy745$9.78$7,286.105,297  
11/17/2017Public Equities L.P. InvusDirectorBuy180,727$10.11$1,827,149.97  
11/15/2017Lonnel CoatsCEOBuy10,000$9.91$99,100.0042,985  
11/14/2017Jeffrey L WadeEVPBuy2,000$9.48$18,960.0050,597  
11/14/2017Public Equities L.P. InvusDirectorBuy575,946$9.64$5,552,119.44  
11/10/2017Public Equities L.P. InvusDirectorBuy145,680$9.74$1,418,923.20  
9/15/2017Lonnel CoatsInsiderBuy30,000$12.54$376,200.00  
9/15/2017Sam L BarkerDirectorBuy1,000$12.50$12,500.0025,623  
6/6/2016James F TessmerVPSell1,500$15.00$22,500.0017,446  
5/23/2016James F TessmerVPSell6,000$13.00$78,000.0021,946  
12/12/2014C.V. InvusDirectorBuy150,000$0.88$132,000.00  
12/10/2014C.V. InvusDirectorBuy315,896$0.90$284,306.40  
11/26/2014International S.C.A. ArtalDirectorBuy149,253,731$1.01$150,746,268.31  
10/25/2013Bryan A KleinleinCFOSell227,626$0.13$29,591.38  
10/9/2013Bryan A KleinleinCFOSell83,281$0.19$15,823.39  
7/9/2013Bryan A KleinleinCFOSell88,235$0.11$9,705.85  
6/27/2013Alexander Richard WalshCEOSell160,000$0.13$20,800.00  
6/18/2013Alexander Richard WalshCEOSell220,000$0.18$39,600.00  
6/7/2013Alexander Richard WalshCEOSell170,000$0.19$32,300.00  
11/21/2012Alexander Richard WalshCEOSell23,700$0.34$8,058.00  
10/23/2012International S.C.A. ArtalDirectorBuy3,000,000$2.25$6,750,000.00  
10/3/2012Alexander Richard WalshCEOSell25,000$0.30$7,500.00  
(Data available from 1/1/2013 forward)












LXRX Insider Trading Activity - Frequently Asked Questions

Who is on Lexicon Pharmaceuticals's Insider Roster?

The list of insiders at Lexicon Pharmaceuticals includes International S.C.A. Artal, and James F Tessmer. Learn more on insiders at LXRX.

What percentage of Lexicon Pharmaceuticals stock is owned by insiders?

6.50% of Lexicon Pharmaceuticals stock is owned by insiders. Learn more on LXRX's insider holdings.

Which Lexicon Pharmaceuticals insiders have been buying company stock?

The following insider purchased LXRX shares in the last 24 months: International S.C.A. Artal ($40,434,500.00).

How much insider buying is happening at Lexicon Pharmaceuticals?

Insiders have purchased a total of 16,173,800 LXRX shares in the last 24 months for a total of $40,434,500.00 bought.

Which Lexicon Pharmaceuticals insiders have been selling company stock?

The following insider sold LXRX shares in the last 24 months: James F Tessmer ($158,551.04).

How much insider selling is happening at Lexicon Pharmaceuticals?

Insiders have sold a total of 22,912 Lexicon Pharmaceuticals shares in the last 24 months for a total of $158,551.04 sold.

This page (NASDAQ:LXRX) was last updated on 10/7/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.